Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-Mcs-332	Fluorescent DID Liposomal Bacterial Membrane Encapsulation Gado-DPTA	Fluorescent DID Liposomal Bacterial Membrane Encapsulation Gado-DPTA is a hybrid theranostic nanocarrier.DiD-labeled liposomes loaded with bacterial outer membrane vesicles and Gd-DTPA were intravenously administered in mice. The hybrid system enabled real-time fluorescent imaging and MRI tracking of immune interactions at infection or tumor sites.	price>
R-Mcs-333	Liposome loaded with 3 peptides(MKARNYLQFLPSKTKVA+WDTCTTYKWQKTLEGHD +KRWLYWQPTLTKMGFVS),100nm	Liposome loaded with 3 peptides(MKARNYLQFLPSKTKVA+WDTCTTYKWQKTLEGHD +KRWLYWQPTLTKMGFVS), 100nm is a multifunctional liposomal peptide delivery system containing three bioactive peptides, each potentially with distinct therapeutic, immunogenic, or targeting properties. The peptides are encapsulated in or associated with the liposomal structure to enhance stability, solubility, and bioavailability.	price>
R-Mcs-334	L-a-PC:Chol:DOPE-dodecanyl(69:30:1molar ratio) Fluorescent Lipid DiI	L-a-PC: Chol: DOPE dodecanil (69:30:1 molar ratio) Fluorescent Lipid DiI is suitable for labeling live cells such as monocytes/macrophages and tumor cells, and observing cell migration and phagocytic behavior in real-time through fluorescence microscopy or flow cytometry. It may also be used to improve the interaction or targeting between liposomes and cell membranes.	price>
R-M1-8762	LNP-cy5/RGD,100nm	Liposome nanoparticles-cy5/RGD can be utilized in various applications, such as cancer imaging, targeted drug delivery, or theranostics (simultaneous diagnosis and therapy).	price>
R-M1-8763	FITC-Ti3C2,200nm-1000nm	FITC-Ti3C2/Fluorescein Isothiocyanate-Ti3C2 has the potential to be used for applications such as fluorescent labeling, bioimaging, drug delivery, or biosensing, where the fluorescence of FITC can be employed for visualization purposes, while the TI3C2 nanoparticles contribute their desirable properties for specific functionalities or carrier capabilities.	price>
R-M1-cs8773	CY7@EScu@ROSlnp-YSAYPDSVPMMS	ROS responsive liposome nanoparticles encapsulate ESCU and CY7 surface modified peptides,CY7@EScu@ROSlnp-YSAYPDSVPMMS from ruixi.This system combines the benefits of ROS-responsive liposome nanoparticles with the specific properties of ESCU and CY7 surface-modified peptides, potentially enabling targeted drug delivery or imaging in ROS-rich environments.	price>
R-M1-cs8774	Cyanine7@ES@ROSlnp-YSAYPDSVPMMS	ROS responsive liposome nanoparticles encapsulate ES and CY7 surface modified peptides.By encapsulating ES and CY7 surface-modified peptides within the ROS-responsive liposome nanoparticles, it is possible to achieve targeted delivery or imaging in ROS-rich environments. The surface modifications on the peptides can facilitate specific interactions with the target cells or tissues, while the ROS-responsive nature of the liposomes regulates the release of the peptides in response to the local ROS levels.	price>
R-M1-cs8799	ROS responsive liposomes loaded with CE6	ROS responsive liposomes loaded with CE6 (chlorin e6) are a type of drug delivery system designed to specifically target and respond to reactive oxygen species (ROS) in the body. Upon destabilization, the liposomes release the CE6 into the surrounding tissues. The released CE6 can then undergo a photochemical reaction when activated by specific wavelengths of light, generating highly reactive singlet oxygen species. This localized generation of singlet oxygen can induce cell death, making it particularly suitable for photodynamic therapy (PDT) applications. By specifically targeting and releasing the CE6 in ROS-rich areas, ROS responsive liposomes loaded with CE6 can enhance the therapeutic efficacy of photodynamic therapy while minimizing off-target effects.	price>
R-M1-9151	Cy5-azide modified SiO2,800nm	Cy5-azide modified SiO2 refers to silicon dioxide (SiO2) nanoparticles that have been modified with the organic dye Cy5 and functionalized with an azide group.It could be used in applications such as fluorescent imaging, drug delivery, or bioconjugation, where the azide group can participate in specific chemical reactions to link the modified nanoparticles to other functional molecules or surfaces.	price>
R-M1-9169	Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin	Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin/Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin from ruixi.We can accept customized products. Ce6: This likely refers to Chlorin e6, a photosensitizer used in photodynamic therapy (PDT) for the treatment of cancer. Ce6 absorbs light and transfers energy to molecular oxygen, creating reactive oxygen species that can destroy nearby cancer cells. Polydopamine: This is a biocompatible and adhesive polymer derived from dopamine. It has been used as a coating material for drug delivery systems due to its versatile surface functionalization and biocompatibility. MIL-101: This is a metal-organic framework (MOF), a class of materials with high porosity and surface area. MIL-101 can be used to encapsulate and deliver drugs due to its porous nature and controllable pore sizes. Gemcitabine: It is a chemotherapy medication used to treat various types of cancers, including bladder cancer, breast cancer, ovarian cancer, and non-small cell lung cancer. Cisplatin: This is a chemotherapy medication used to treat various types of cancers, including testicular, ovarian, bladder, and lung cancers.	price>

...